The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Scope Fluidics Spolka Akcyjna's share price is €24.00.
Scope Fluidics Spolka Akcyjna's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.03. Hence, Scope Fluidics Spolka Akcyjna's PS Ratio for today is 827.59.
The historical rank and industry rank for Scope Fluidics Spolka Akcyjna's PS Ratio or its related term are showing as below:
FRA:S84'
s PS Ratio Range Over the Past 10 Years
Min: 449.1 Med: 15300 Max: 228000
Current: 983.87
During the past 10 years, Scope Fluidics Spolka Akcyjna's highest PS Ratio was 228000.00. The lowest was 449.10. And the median was 15300.00.
FRA:S84's PS Ratio is ranked worse than 99.5% of 201
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.82
vs FRA:S84: 983.87
During the past 10 years, Scope Fluidics Spolka Akcyjna's highest 3-Year average Revenue per Share Growth Rate was -40.20% per year. The lowest was -40.20% per year. And the median was -40.20% per year.
Back to Basics: PS Ratio
Scope Fluidics Spolka Akcyjna (FRA:S84) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Scope Fluidics Spolka Akcyjna PS Ratio Related Terms
Scope Fluidics Spolka Akcyjna PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Scope Fluidics Spolka Akcyjna's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scope Fluidics Spolka Akcyjna PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Scope Fluidics Spolka Akcyjna's PS Ratio distribution charts can be found below:
* The bar in red indicates where Scope Fluidics Spolka Akcyjna's PS Ratio falls into.
Scope Fluidics Spolka Akcyjna PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Scope Fluidics Spolka Akcyjna's Share Price of today is €24.00. Scope Fluidics Spolka Akcyjna's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Scope Fluidics Spolka Akcyjna (FRA:S84) has a PS Ratio of 827.59 as of Jul. 12, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. This is 95% below median its historical median of 15,300.00. Over the past decade, Scope Fluidics Spolka Akcyjna's PS Ratio has ranged from 449.10 to 228,000.00. According to the industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #200 out of 201 companies in the Medical Diagnostics & Research industry, placing it in the top 99.5%.
Is Scope Fluidics Spolka Akcyjna's PS Ratio too high?
Scope Fluidics Spolka Akcyjna's current PS Ratio of 827.59 is 95% below median its 10-year median of 15,300.00. Over the past 10 years, this metric has ranged from a low of 449.10 to a high of 228,000.00. The Medical Diagnostics & Research industry median PS Ratio is 2.82. Scope Fluidics Spolka Akcyjna's value of 827.59 is 29247.2% above this industry median. Based on the distribution chart, Scope Fluidics Spolka Akcyjna ranks #200 out of 201 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Scope Fluidics Spolka Akcyjna has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Scope Fluidics Spolka Akcyjna's PS Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Scope Fluidics Spolka Akcyjna ranks #200 out of 201 companies for PS Ratio. This places Scope Fluidics Spolka Akcyjna in the lower half of its industry. The industry median PS Ratio is 2.82. Scope Fluidics Spolka Akcyjna's value of 827.59 is 29247.2% above this benchmark. Historically, Scope Fluidics Spolka Akcyjna's own PS Ratio has ranged from 449.10 to 228,000.00 over the past decade. While the company's 10-year median is 15,300.00 vs. the industry median of 2.82, Scope Fluidics Spolka Akcyjna has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.82, based on 201 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scope Fluidics Spolka Akcyjna's current PS Ratio of 827.59 is 29247.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Scope Fluidics Spolka Akcyjna and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scope Fluidics Spolka Akcyjna's current PS Ratio is 827.59, which is 95% below median its own 10-year median of 15,300.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scope Fluidics Spolka Akcyjna stock overvalued right now?
Scope Fluidics Spolka Akcyjna (FRA:S84) has a current PS Ratio of 827.59. The stock's GF Value™ is €25.43, compared to a current price of €24.00 — trading 5.6% below its estimated fair value. The current PS Ratio is 827.59, which is 95% below median its 10-year median of 15,300.00 and 29247.2% above the Medical Diagnostics & Research industry median of 2.82. Scope Fluidics Spolka Akcyjna's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Scope Fluidics Spolka Akcyjna (FRA:S84), the current PS Ratio is 827.59 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scope Fluidics Spolka Akcyjna (FRA:S84) Overvalued in 2026?
Based on GuruFocus' analysis, Scope Fluidics Spolka Akcyjna stock appears to be undervalued.
The current stock price of €24.00 is trading 5.6% below its estimated GF Value™ of €25.43.
Key valuation signals for FRA:S84:
PS Ratio: 827.59 (95% below median its 10-year median of 15,300.00)
GF Value™: €25.43 vs. price of €24.00 (5.6% below fair value)
Industry Position: 29247.2% above the Medical Diagnostics & Research median (#200 of 201)
No single metric tells the full story. See the FRA:S84 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scope Fluidics Spolka Akcyjna Business Description
Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.
50GF Score
Get the complete analysis for FRA:S84
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S84 has been successfully added to your 
